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Research Paper
Psychological factors predict an unfavorable pain
trajectory after hysterectomy: a prospective cohort
study on chronic postsurgical pain
Patrı´cia R. Pintoa,b,*, Teresa McIntyrec, Vera Arau´jo-Soaresd, Armando Almeidaa,b, Patrı´cio Costaa,b,e
Abstract
Chronic postsurgical pain (CPSP) is a well-recognized potential complication with negative personal, social, and health care
consequences. However, limited data exist on CPSP and on the course of pain over time after hysterectomy. Using data from
a prospective cohort study on a consecutive sample assessed at 4 time points, presurgery (T1), 48 hours (T2), 4 months (T3), and 5
years postsurgery (T4), we sought to examine women’s PSP trajectories using assessments of pain at T3 and T4. In addition, this
study aimed to investigate presurgical and postsurgical risk factors associated with an unfavourable pain trajectory (PT). Based on
pain data collected at T3 and T4, 3 distinct trajectories of PSP emerged: no CPSP (PT1; n5 88), prolonged PSP (PT2; n5 53), and
CPSP (PT3; n5 29). Moreover, reported CPSP prevalence at 5 years was 17.1%. Multinomial logistic regression models controlling
for age, presurgical pain, and type of hysterectomy tested for baseline and acute postsurgical predictive variables. Membership in
PT2 and PT3 was predicted by presurgical anxiety (odds ratio [OR] 5 1.131, P 5 0.015; OR 5 1.175, P 5 0.009, respectively),
emotional representation of the surgical disease (OR 5 1.155, P 5 0.034; OR 5 1.213, P 5 0.020, respectively), and pain
catastrophizing (OR 5 1.079, P 5 0.043; OR 5 1.143, P 5 0.001, respectively). Furthermore, acute PSP intensity and frequency
determined membership of women in PT3 (OR5 1.211, P5 0.033; OR5 3.000, P5 0.029, respectively), and postsurgical anxiety
(OR5 1.182, P5 0.026) also played a key predictive role. This study identified factors that can be easily screened before and after
surgery and are amenable to change through carefully designed timely and tailored interventions for women at risk of an unfavorable
PSP trajectory posthysterectomy.
Keywords: Hysterectomy, Postsurgical pain trajectory, Chronic postsurgical pain, Prospective cohort study, Psychological
factors, Acute postsurgical pain
1. Introduction
Chronic pain after surgery is a well-recognized potential
complication, being acknowledged as a major clinical problem
with significant individual, social, and health care costs.51,55,59 It is
a serious public health issue because surgeries are widely
performed, increasing the numbers of those at risk.13,48,55
Indeed, the current version of the International Classification of
Diseases (ICD-11) for chronic pain categorization already
proposes chronic postsurgical pain (CPSP) as a new distinct
entity among 7 groups of chronic pain disorders.102
Chronic PSP was first mentioned in 1998,26 being highlighted
that 22.5% of patients attending 10 pain clinics pointed surgery
as the cause of chronic pain. Despite improvements in
knowledge regarding epidemiology and CPSP burden, its
underlying mechanisms are not fully understood.47,104 However,
evidence suggests that CPSP development is multifactorial,
rooted in a dynamic and complex interplay among biological,
psychosocial, and environmental factors.23,48 To increase
knowledge, research has focused increasingly on understanding
risk factors, in hopes of finding new ways to treat and ultimately
prevent CPSP from occurring.
Risk factors are often conceptualized into presurgical,
intrasurgical, and postsurgical, embracing variables such as
age, surgery type, previous pain, and acute PSP.51,52,59,62,73
Psychological factors are well-documented predictors for
CPSP across different surgeries,2,15,41,44,61,76 including anx-
iety,58,61,99 depression,108 pain catastrophizing,28,50,56,58,99
and optimism.40,82 In an attempt to systematize information,
VanDenKerkhof et al.104 proposed a framework wherein risk
factors are organized into 5 domains: demographic, pain,
clinical, surgery related, and psychological.
Hysterectomy is the most common gynecologic surgery
performed in women in Western countries.85,98 In a review
including 11 hysterectomy studies, with follow-up times up to 2
years, CPSP was reported by 5% to 32% of women.8
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Subsequent studies kept diverging on prevalence rates. These
differences were likely due to distinct CPSP definitions,
heterogeneity of measurement, and differences in follow-up
times; some were 3,100 4,6,67,79 6 months,80,103 17,67,100 or 2
years.67 Simultaneously, risk factors that have been most
highlighted were age,67,79 presurgical pain,7,67,100,103 other
pain problems,6,7,67,79 and psychological factors.67,79,100,103
Within the latter, there was some heterogeneity because of
different measures used. Furthermore, acute PSP intensity
was more strongly related with CPSP in some hysterectomy
studies6,100,103 than in others,67,79 with one of the studies
proposing PSP frequency as a better predictor than
intensity.79
Although the incidence and risk factors for CPSP have been
widely explored, knowledge on the course of PSP over time is
limited. Identifying patients who are at risk of an unfavorable pain
trajectory (PT), culminating in CPSP, provides a unique oppor-
tunity to investigate the transition from acute to chronic pain and
is critical to developing a more comprehensive understanding of
CPSP and establishing potential targets for psychosocial and
clinical interventions.
Therefore, the aims of this study were: (1) to examine PSP
trajectory up to 5 years after hysterectomy; (2) to investigate
baseline predictors of different pain trajectories; and (3) to further
explore the added predictive value of acute postsurgical factors in
pain chronification.
2. Methods
2.1. Participants and procedure
This study was conducted in a central hospital in northern
Portugal and approval was granted by the Hospital Ethics
Committee. This was a prospective cohort study with
longitudinal assessments at 4 time points: 24 hours before
surgery (T1), 48 hours (T2), 4 months (T3), and 5 years (T4) after
surgery. Assessments were performed between March 2009
and January 2015. A consecutive sample of 203 women,
undergoing hysterectomy due to benign causes, was invited to
participate in the study and all provided written informed
consent. Inclusion criteria were age between 18 and 80 years,
and the ability to understand consent procedures and
questionnaire materials. Exclusion criteria were the presence
of psychiatric or neurologic pathology (eg, dementia) and
undergoing hysterectomy due to malign conditions or in
emergency setting. Time 1 and T2 assessments took place
in hospital, T3 and T4 follow-up assessments were conducted
by telephone interview. Inclusion in each assessment point
and the reasons for loss to T2, T3, and T4 are shown in
a flowchart (Fig. 1). The final sample is comprised of 170
women (retention rate: 83.7%; age: M 5 50.8; SD 5 9.03;
minimum 5 35; maximum 5 76) with assessments performed
at T1, T2, T3, and T4. The 33 women lost to follow-up, from T1
to T4, did not differ significantly from the women evaluated
over 5 years in terms of baseline demographic, psychological,
and clinical characteristics, namely on surgical, anesthetic,
and analgesic issues.
Data related to this sample have been described in 4
previous publications reporting predictors of acute PSP,75,76
predictors of rescue analgesia administration,78 and predic-
tors of persistent PSP 4 months after hysterectomy.79 The
present work is the first to report the long-term outcomes in
this sample, 5 years posthysterectomy, including the 4
assessment points.
2.2. Data collection
2.2.1. Presurgical assessment—24 hours before surgery (T1)
At hospital admission, and to get a baseline evaluation of women,
the Portuguese versions of the following questionnaires were
administered, in a face-to-face interview, by a trained health
psychologist.
2.2.1.1. Sociodemographic Questionnaire
Included questions on age, height, weight, education, residence,
marital status, professional status, household, and parity.
2.2.1.2. Clinical Questionnaire
Enquired about previous pain, either related to the cause of
surgery or due to other causes, previous surgeries, menopause
status, diagnosis/indication for hysterectomy and disease onset,
uterus height andweight, aswell as the use of psychotropic drugs
(anxiolytics and antidepressants).
2.2.1.3. The Brief Pain Inventory—short form
Used among women reporting presurgical pain (related with the
disease underlying the surgery).24 It measured pain location in the
body; pain intensity on an 11-point numerical rating scale (NRS;
0 represents “no pain” and 10 the “worst pain imaginable”);
analgesic intake; perception of analgesic relief; and pain in-
terference with daily life on an 11-point NRS (0 5 “does not
interfere” and 105 “completely interferes”) in distinct dimensions
(general activity, mood, walking, work, relations with others,
sleep, and enjoyment of life). Higher scores represent higher
levels of pain interference. In this study, the internal consistency
reliability27 for the pain interference subscale scores was high (a
5 0.90).
2.2.1.4. The Hospital Anxiety and Depression Scale
Comprised by 2 subscales used to measure anxiety and
depression through 7 items each.110 Subscale scores range
from 0 to 21 and result from the sum of each item (Likert scale
ranging from 0 to 3). Higher scores correspond to higher levels of
anxiety and depression. In the current sample, internal consis-
tency reliability was adequate for both anxiety (T1: a5 0.77; T2: a
5 0.84) and depression (T1: a 5 0.81).
2.2.1.5. The Surgical Fear Questionnaire
Used to evaluate specific surgical fears through 8 items
aggregated in 2 subscales, “fear of immediate consequences of
surgery” (a5 0.77; 4 items) and “fear of long-term consequences
of surgery” (a 5 0.75; 4 items).101 Each item score ranges from
0 to 10; item scores are summed to calculate each total subscale
score. Subscale scores range between 0 and 40, with higher
values indicating higher levels of fear.
2.2.1.6. The Revised Illness Perception Questionnaire
Used to assess patient beliefs about the underlying disease
that lead to surgery, is comprised by 7 dimensions.68 In the
current study, and with the aim of diminishing participant
burden, a psychometrically shortened version77,79 was used,
with 3 items composing each one of the 7 subscales: “timeline
acute/chronic” (a 5 0.79; eg, “My illness will last for a long
time”); “timeline cyclical” (a 5 0.74; eg, “My symptoms come
and go in cycles”); “consequences” (a 5 0.56; eg, “The
disease underlying surgery has major consequences on my
life”); “personal control” (a 5 0.53; eg, “I have the power to
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influence my illness”); “treatment control” (a 5 0.76; eg,
“Surgery can control my illness”); “illness coherence” (a 5
0.78; eg, “My illness is a mystery for me”); and “emotional
representation” (a5 0.88; eg, “When I think about my illness I
get upset”). “Consequences” and “personal control” were not
included because of their low score reliability in this sample (a
5 0.56 and a 5 0.53, respectively). Each item is rated on
a scale of 1 to 5 and to calculate each total subscale score,
items are summed. Each subscale varies between 5 and 15,
with high scores revealing less adaptive illness perceptions,
with the exception of personal and treatment control sub-
scales, which score inversely.
2.2.1.7. The Coping Strategies Questionnaire—revised form
Used to evaluate 6 pain coping strategies: “pain catastroph-
izing” (5 items; a 5 0.88); “praying and hoping” (3 items; a 5
0.88); “ignoring pain” (5 items; a5 0.92); “distraction/diverting
attention” (5 items; a 5 0.77); “reinterpreting pain” (4 items; a
5 0.74); and “pain coping self-statements” (4 items; a5 0.70).
During pilot testing, subjects were often confused by the usual
7-point Likert-type scale.87 Therefore, a 5-point rating scale
was used (1 5 never, 2 5 almost never, 3 5 sometimes, 4 5
almost always, and 5 5 always), which was shown to be more
easily understood. The total subscale score was obtained by
the sum of the item scores, with higher scores indicating
greater use of the specific coping strategy.
2.2.1.8. Life Orientation Test—revised
Evaluated the personality trait optimism using 8 items.92 The total
score ranges from 0 to 12 (a5 0.95), with high values associated
with more optimism.
2.2.2. Postsurgical assessment—48 hours after surgery (T2)
Forty-eight hours after surgery, women were again assessed in
a face-to-face interview by the same psychologist who performed
the baseline assessment in T1.
2.2.2.1. Acute postsurgical pain measurement
Worst and average levels of acute pain intensity, within the first 48
hours after surgery, were assessed using an 11-point NRS (from
the BPI-SF described above).24
The PSP frequency assessment was performed using the
frequency scale of the McGill Pain Questionnaire.66 Pain could
be defined either as constant (continuous and steady),
intermittent (periodic and rhythmic), or brief (momentary and
transient).
2.2.2.2. Postsurgical anxiety
Postsurgical anxiety was evaluated again at this time point using
the Hospital Anxiety and Depression Scale anxiety subscale110
already described.
Figure 1. Flowchart of women undergoing hysterectomy.
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2.2.3. Postsurgical assessment—4 months (T3) and 5 years
after surgery (T4)
Four months and 5 years after surgery, telephone calls were
made to every participant to check for the presence of pain.
The question was: “Do you still have any pain that you could
link to surgery or that you could relate to the surgical
procedure?” This is an adaptation of the BPI-SF first question
on pain prospection. If women answered no, those women
were classified as cases without pain. Contrarily, if women
answered yes, they were considered pain cases. For those
women reporting pain, additional measures were used, which
focused on pain assessment.
2.2.3.1. The Brief Pain Inventory—short form
As described above.24
2.2.3.2. Pain frequency description
Pain frequency could be described as constant, daily, several
times a week but not daily, several times a month but not weekly,
during sexual intercourse, by touch or lifting weight.
2.2.3.3. Neuropathic Pain Questionnaire (DN-4)
Previous research described CPSP as a potential neuropathic
pain.4,48,51 This instrument assesses pain characteristics/quality
using 10 items. Seven of them refer to specific pain sensory
descriptors, such as burning, pinpricking or numbness, and
patients answer if their pain has those characteristics using
a dichotomous response format (yes or no). The last 3 items result
from the sensory examination of patients performed by a clinician.
For the purpose of this study, only the first 7 itemswere included.5
Besides the information regarding pain quality, this questionnaire
also provides information concerning the potential likelihood of
neuropathic pain, corresponding to a cutoff of 3 (DN4 $ 3).
2.3. Surgical procedures, anesthetic, and
analgesic techniques
Clinical data related to the surgery, anesthesia and analgesia
were collected from medical records.
Regarding surgical procedure, among the 170 women who
underwent surgery, 122 (71.8%) were submitted to total
abdominal hysterectomy, 31 (18.2%) to vaginal hysterectomy,
11 (6.5%) to total laparoscopic hysterectomy, and 6 (3.5%) to
laparoscopically assisted vaginal hysterectomy. In abdominal
hysterectomy (n5 122), a Pfannenstiel incision was performed in
102 women (83.6%), being established as the first choice, with
a vertical infraumbilical incision being performed in 20 women
(16.4%), corresponding to cases wherein a previous vertical
surgical scar was present.
Concomitant procedures, such as oophorectomy, ovarian
cystectomy, salpingectomy, cystoscopy, or vaginal repair, were
also performed in a few patients. Moreover, uterus weight and
height were also recorded.
Concerning the type of anesthesia, 51 (30.0%) patients had
general anesthesia, 22 (12.9%) had locoregional, and 97 (57.1%)
were submitted to combined anesthesia (general1 locoregional).
ASA score (physical status classification of the American Society
of Anesthesiologists) was recorded, including cases of ASA grade
I (49, 28.8%), II (107, 62.9%), and III (14, 8.2%).
In what regards analgesic procedures, a postsurgical 48 hours
standardized analgesia protocol was assigned to all patients. This
protocol was established and supervised by the Acute Pain
Service, before the transferring of patients to the infirmary.
Delivery of the analgesic protocol was either epidural or
intravenous. The standardized epidural protocols could be: (1)
a continuous epidural infusion delivered infusion balloon with
ropivacaine (0.1%) and fentanyl (3 mg/mL), administrated to 105
(61.8%) women; or (2) administration of an epidural morphine
bolus (2-3 mg, 12/12 h), assigned to 14 (8.2%) women. The
intravenous protocol consisted in a continuous intravenous
infusion delivered infusion balloon of tramadol (600 mg),
metamizol (6 g), and metoclopramide (60 mg) and was used
with 51 (30.0%) patients.
Paracetamol (1 g 6/6 h) and nonsteroidal anti-inflammatory
drugs (ketorolac 30mg 12/12 h or parecoxib 40mg 12/12 h) were
always included as coadjuvant analgesics. In addition, all
analgesic regimens included prokinetic treatment that was
standardized to metoclopramide (10 mg intravenously 8/8 h). In
cases of moderate or severe acute PSP levels (NRS. 3), rescue
analgesia was prescribed beyond the standardized analgesic
protocol. Because of the great variability in analgesics’ protocol
and dosages, no attempt was made to determine total
equianalgesic medication dosages. Instead, it was recorded
whether rescue analgesics were given to patients or not.
The use of psychotropic drugs (anxiolytics and antidepres-
sants) during hospital stay was detailed from hospital records.
2.4. Statistical analyses
The primary outcome variable under study is PSP trajectory,
corresponding to 3 possible PT groups: (1) No CPSP or pain
trajectory 1 (PT1), comprised by women who did not report pain
neither at 4months nor at 5 years after surgery; (2) prolonged PSP
or pain trajectory 2 (PT2), including women who complained of
pain 4months after surgery, but not 5 years after; and (3) CPSP or
pain trajectory 3 (PT3), comprising those women who
reported pain both at 4 months and 5 years after hysterectomy.
These groups were defined taking into account pain report (yes
[presence] or no [absence]) 4 months and 5 years after
hysterectomy (T3 and T4).
To compare the 3 groups on the variables under analysis, chi-
square or Fisher tests and one-way analysis of variance statistical
tests were computed. For the latter, in the case of significant
results (P , 0.05), Bonferroni post hoc tests were performed to
further investigate between-group differences. These preliminary
analyses were exploratory and were performed to determine the
predictor variables to include in the subsequent regression
analyses.
Finally, a set of predictive multinomial logistic regression
models were conducted to investigate risk factors associated
with PT group membership. The sociodemographic, clinical, and
psychological variables selected for the regression analyses were
those that distinguished PT groups in univariate analyses. Two
structural models were developed: model 1 (M1), investigating
the role of baseline presurgical variables (T1), allowing for the
establishment of a presurgical risk profile; and model 2 (M2),
aiming at further understanding the role of acute postsurgical
factors, 48 hours after hysterectomy (T2). These basic structural
models, include demographic (age) and clinical (pain-related
[presurgical pain] and surgery-related [type of hysterectomy])
variables that significantly distinguished the groups in univariate
analyses, to control these effects in group comparisons.
Considering the role of presurgical baseline predictors, and
due to shared variance among the 5 psychological predictors
(and consequent multicollinearity), which emerged as significant
in the distinction of the 3 groups, 3 different submodels were
considered. The first model (M1A) focused on emotional variables
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(presurgical anxiety and fear), the second (M1B) centered on
illness perceptions (emotional representation of the disease
underlying surgery), and the third model (M1C) tested the role
of pain coping strategies (pain catastrophizing).
Regarding acute postsurgical factors, 2 models were com-
puted, both controlling for the same abovementioned de-
mographic and clinical variables that were controlled for in
presurgical models. Beyond these covariates, the first model
(M2A) tested for the specific predictive role of acute PSP intensity
and frequency. The second postsurgical model (M2B) was akin to
the first, although it had the addition of postsurgical anxiety.
Data were analyzed using the IBM SPSS Statistics version
24.0. Internal consistency of responses to the questionnaires was
assessed using Cronbach alpha.27 Results were considered
significant for P values , 0.05. Effect size (ES) measures were
interpreted considering theCohen25 rule of thumb for eta squared
(h2): small ES 5 0.02; medium ES5 0.13; large ES 5 0.26; and
Rea and Parker84 for Cramer phi (w) or Cramer V for nominal data:
negligible association: 0 and under 0.10; weak association: 0.10
and under 0.20; moderate association: 0.20 and under 0.40;
relatively strong association: 0.40 and under 0.60; strong
association: 0.60 and under 0.80; and very strong association:
0.80 and under 1.00.
3. Results
3.1. Pain trajectory according to pain report 4 months (T3)
and 5 years (T4) after hysterectomy
Table 1 presents the number of women within each PT group,
according to the course of pain up to 5 years after surgery.
Considering PT, 88 (51.8%, PT1) women did not complain of
pain at 4 months or 5 years after surgery. This was the largest
group and was called “No Chronic Post-Surgical Pain.” This PT is
a typical, expected, and desirable one in terms of healing and
normal recovery. The second groupwas comprised of 53 (31.2%,
PT2) women who complained of pain 4 months postsurgery, but
at 5 years after surgery did not experience any related pain. This
group was labelled “Prolonged Post-Surgical Pain.” The third PT
group (PT3) included 29 (17.1%) women who reported pain both
at 4 months and 5 years after hysterectomy. As their pain
persisted over time, this group was labelled “Chronic Post-
Surgical Pain.” All patients reporting pain at the 5-year follow-up
also had reported pain at 4 months postsurgery. Patients not
reporting pain at the 4-month follow-up also did not report pain 5
years later. Thus, there were no cases of “new pain” with a later
onset beyond the 4-month follow-up time point.
3.2. Differences among pain trajectory groups on
sociodemographic, clinical, and psychological variables
Table 2 shows that before surgery, PT groups differed in age
(P 5 0.013; h2 5 0.051, small ES), with PT1 being older than
PT2 (P 5 0.003). Concerning clinical measures, the groups
were similar in terms of surgical disease onset, body mass
index, previous surgical procedures, or presurgical psycho-
tropic use. Regarding presurgical pain, the 3 groups of women
differed significantly on presurgical pain related to the
condition underlying surgery (P5 0.032; w5 0.201, moderate
association), but not on previous chronic pain because of other
causes (Table 2). Among the 3 empirically derived PT groups,
and regarding psychological variables measured before
surgery, there were significant differences in anxiety (P ,
0.001; h25 0.094, small ES), surgical fear related to long-term
consequences of surgery (P 5 0.022; h2 5 0.045, small ES),
emotional representation of surgical disease (P 5 0.001; h2 5
0.081, small ES), and pain catastrophizing (P , 0.001; h2 5
0.090, small ES). For all these variables, higher values were
associated with chronic pain groupmembership in PT2 or PT3.
In terms of surgery, the PT groups could be distinguished
based on the type of surgical approach (P 5 0.007; w 5 0.242,
moderate association) and among those undergoing abdominal
hysterectomy, there were also differences across groups on the
type of abdominal incision (P 5 0.003; w 5 0.260, moderate
association). The PT2 and PT3 groups had more women
undergoing abdominal hysterectomy and a Pfannenstiel incision.
In the acute postsurgical period, 48 hours after surgery, the 3
PT groups of women showed differences in acute pain report,
regarding worst (P , 0.001; h2 5 0.096, small ES) and average
(P 5 0.001; h2 5 0.086, small ES) pain intensity, pain frequency
(P 5 0.001; w 5 0.286, moderate association), and postsurgical
anxiety (P , 0.001; h2 5 0.109, small ES). These differences
showed that the PT2 and PT3 groups scored more negatively on
these variables.
3.3. Pain incidence, characteristics, and perceived impact 5
years after hysterectomy
Among the 170 women who completed the 4 assessments, 29
(17.1%) revealed an unfavorable PT after hysterectomy, reporting
pain both at 4 months and 5 years after surgery, therefore being
considered CPSP cases (Table 3). From these 29 cases of
CPSP, Table 3 highlights that in terms of pain frequency, most
women (44.8%) reported pain several times a week, with 24.2%
ofwomen perceiving pain on a daily basis and 20.7%complaining
of pain only during sexual intercourse or by touch. In addition, the
mean of worst pain intensity was 3.17 (SD5 1.61) and the mean
average level of pain intensity was 1.89 (SD5 0.88), on the 0 to 10
NRS. It was also shown that 34.5% of CPSP women rated their
worst pain intensity above 3 (NRS. 3), indicating moderate and/
or severe pain levels. Table 3 also reveals that the pain sensory
characteristics more often described by patients with CPSPwere
feeling of pins and needles (51.7%) and numbness (31.0%). In
terms of a potential neuropathic pain component of CPSP, 5
(17.2%) women presented a DN4 $ 3 value. Pain interference
Table 1
Pain trajectory groups according to pain report at 4 months (T3) and 5 years (T4) after hysterectomy.
Pain trajectories Chronic pain report (N 5 170) n (%) Group designation
T3 (4 mo after surgery) T4 (5 y after surgery)
Pain trajectory 1 No No 88 (51.8) No chronic postsurgical pain
Pain trajectory 2 Yes No 53 (31.2) Prolonged postsurgical pain
Pain trajectory 3 Yes Yes 29 (17.1) Chronic postsurgical pain
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was reported in all domains, the most common being mood
(57.1%), enjoyment of life (50.0%), general activity (42.9%),
normal work (42.9%), and walking ability (28.6%). Nevertheless,
mean values of pain interference were in the low-to-medium
range.
3.4. Predictors of postsurgical pain trajectory
To identify the presurgical predictors of an unfavorable PT, 3
multinomial regression models were computed (Table 4), con-
trolling for the demographic and clinical variables that distin-
guished the 3 groups: age, previous surgical pain, and type of
hysterectomy. The first model (M1A) further tested for the
influence of psychological factors related to emotional distress,
namely presurgical anxiety and surgical fear related to the long-
term consequences of surgery. Table 4 shows that presurgical
anxiety is a predictor of PT, being a determinant of group
membership, with higher anxiety scores being associated with
both the “Prolonged PSP group” (PT2; odds ratio [OR]5 1.131, P
5 0.015; for each unit increased in presurgical anxiety, the odds
of being in the PT2 group is 1.131 times higher than those of being
in the PT1 group) and the “CPSP group” (PT3; OR5 1.175, P5
0.009), when compared with the “No CPSP group” (PT1). All
other variables were not significant. Table 4 also reveals results
on the influence of psychological factors associated with illness
perceptions (M1B) and pain coping strategies (M1C). Within
Table 2
Differences between pain trajectory groups on sociodemographic, clinical, and psychological variables measured 24 hours
before (T1) and 48 hours after hysterectomy (T2).
Measures PT1 (n 5 88) PT2 (n 5 53) PT3 (n 5 29) F/x2 P h2/w
Presurgical data 24 h before surgery-T1
Sociodemographic: Age (y [SD]) 52.8 (10.2)a 48.7 (6.43)b 48.7 (8.19)ab 4.446 0.013 0.051
Presurgical clinical variables
Disease onset (mo) 39.2 (48.6) 36.3 (46.0) 44.9 (71.4) 0.250 0.779 0.003
BMI (kg/m2) 28.8 (4.26) 29.0 (4.78) 27.9 (4.15) 0.585 0.558 0.007
Previous surgeries (yes) 62 (70.5%) 37 (69.8%) 21 (72.4%) 0.063 0.969 0.019
Psychotropic use* (yes) 28 (33.7%) 19 (37.3%) 14 (48.3%) 1.941 0.379 0.109
Presurgical pain (yes) 44 (50.0%) 36 (67.9%) 21 (72.4%) 6.858 0.032 0.201
Previous pain due to other causes† (yes) 49 (55.7%) 37 (69.8%) 21 (72.4%) 4.176 0.124 0.157
Psychological variables (range)
HADS: anxiety (0-21) 6.02 (3.84)b 7.87 (3.96)a 9.38 (4.81)a 8.615 <0.001 0.094
HADS: depression (0-21) 1.89 (2.48) 2.68 (3.71) 2.69 (2.93) 1.509 0.224 0.018
SFQ: immediate consequences (0-40) 9.02 (8.55) 10.8 (7.26) 13.3 (10.1) 2.892 0.058 0.033
SFQ: long-term consequences (0-40) 4.61 (6.78)b 4.66 (5.33)b 8.41 (8.12)a 3.929 0.022 0.045
IPQ-R: timeline acute/chronic (3-15) 6.11 (1.39) 5.98 (1.01) 6.52 (1.53) 1.607 0.204 0.019
IPQ-R: timeline cyclical (3-15) 6.94 (3.09) 7.85 (3.20) 8.28 (3.36) 2.530 0.083 0.029
IPQ-R: treatment control (3-15) 12.2 (0.98) 12.2 (0.77) 12.1 (0.75) 0.231 0.794 0.003
IPQ-R: illness coherence (3-15) 9.27 (2.76) 9.36 (2.60) 9.90 (2.58) 0.604 0.548 0.007
IPQ-R: emotional representation (3-15) 7.60 (2.89)b 9.04 (2.90)a 9.62 (2.68)a 7.383 0.001 0.081
CSQ-R: pain catastrophizing (6-30) 9.25 (4.28)b 11.3 (5.81)ab 13.6 (6.50)a 8.232 <0.001 0.090
CSQ-R: praying/hoping (3-15) 9.57 (4.22) 10.0 (4.04) 10.5 (3.67) 0.560 0.573 0.007
CSQ-R: ignoring (5-25) 12.4 (5.81) 11.9 (6.18) 11.0 (6.12) 0.568 0.568 0.007
CSQ-R: diverting attention (5-25) 9.70 (4.70) 10.2 (4.54) 9.86 (4.76) 0.213 0.808 0.003
CSQ-R: reinterpreting pain (4-20) 6.71 (3.23) 7.00 (3.52) 6.96 (3.88) 0.133 0.876 0.002
CSQ-R: pain coping self-stat (4-20) 16.0 (3.61) 15.9 (3.53) 14.9 (3.57) 1.092 0.338 0.014
LOT-R: optimism (0-12) 7.30 (3.48) 6.63 (3.01) 7.14 (3.25) 0.663 0.517 0.008
Postsurgical variables-T2
Type hyst‡: open abdominal 54 (61.4%) 43 (81.1%) 25 (86.2%) 9.978 0.007 0.242
Abdom. Incis.§: Pfannenstiel 42 (47.7%) 39 (73.6%) 21 (72.4%) 11.460 0.003 0.260
Uterus weight (g) 219 (220) 217 (207) 205 (213) 0.045 0.956 0.001
Uterus height (cm) 9.61 (2.65) 9.30 (2.70) 9.49 (2.62) 0.228 0.797 0.003
Worst pain intensity‖ 4.40 (2.85)b 5.70 (2.79)a 6.86 (3.03)a 8.853 <0.001 0.096
Average pain intensity‖ 2.59 (1.61)b 3.55 (1.58)a 3.55 (1.43)a 7.901 0.001 0.086
Pain frequency{: constant 17 (19.3%) 18 (34.0%) 16 (55.2%) 13.928 0.001 0.286
HADS: anxiety 2.05 (2.50)b 3.23 (3.83)b 5.21 (4.36)a 10.18 <0.001 0.109
Psychotropic use* (yes) 33 (37.5%) 21 (39.6%) 14 (50%) 1.392 0.498 0.091
Length of stay (d) 3.10 (0.94) 3.00 (0.56) 3.00 (0.48) 0.373 0.689 0.005
Continuous variables are presented as mean (SD); categorical variables are presented as n (%).
Different letters represent P values, 0.05 in analysis of variance post hoc tests; for example, in age groups comparisons, PT1 (represented with a) is significantly different from PT2 (represented with b) and PT3 does not
significantly differ from PT1 and PT2 (represented with ab).
* Psychotropic use: consumption/intake of anxiolytics and antidepressants.
† Other previous chronic pain states not related to the cause of surgery.
‡ Type of hysterectomy: n (%) of open abdominal hysterectomies vs abdominal laparoscopic, vaginal, and vaginal-assisted laparoscopic.
§ Abdominal incision: n (%) of Pfannenstiel incisions vs infraumbilical vertical incision and laparoscopies.
‖ NRS 5 numerical rating scale 0 to 10 from Brief Pain Inventory (BPI).
{ Pain frequency: constant pain vs intermittent or brief pain, assessed through frequency subscale of McGill Pain Questionnaire.
BMI, body mass index; CSQ-R, Coping Strategies Questionnaire-Revised; HADS, Hospital Anxiety and Depression Scale; IPQ-R, Illness Perception Questionnaire-Revised; LOT-R, Life Orientation Test-revised; PT, pain
trajectory; SFQ, Surgical Fear Questionnaire.
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M1B, emotional representation of the condition underlying
surgery emerged as the only factor significantly associated with
group membership, with high scores predicting PT2 (OR 5
1.165, P 5 0.018) and PT3 (OR 5 1.246, P 5 0.005)
membership. Within M1C, pain catastrophizing was the only
variable yielding a significant association with either membership
in PT2 (OR5 1.079, P5 0.043) or PT3 (OR5 1.143, P5 0.001)
groups. Concerning factors that could distinguish PT2 from PT3
membership, Table 4 indicates that the psychological construct
fear of long-term consequences of surgery was the only
significant predictor (OR 5 1.078, P 5 0.049).
To further explore the role of acute postsurgical variables in
the development of an unfavorable PT, over and above
demographic and clinical factors, 2 subsequent models were
tested (Table 5). The first model (M2A) revealed that acute PSP
intensity and frequency determined inclusion of women in PT3
(OR 5 1.211, P 5 0.033 and OR 5 3.000, P 5 0.029,
respectively). The second postsurgical model (model 2B)
added postsurgical anxiety to the variables of the previous
model to test its predictive role. Subsequently, both acute PSP
intensity and frequency ceased to be significant and post-
surgical anxiety became the only variable predicting PT3
(CPSP) (OR5 1.182, P5 0.026). Age, previous pain, and type
of hysterectomy did not contribute to the prediction of an
unfavorable PT in any of the models (Tables 4 and 5).
4. Discussion
This prospective cohort study followed women up to 5 years after
hysterectomy and found that presurgical anxiety, emotional
illness representations, and pain catastrophizing were risk factors
for PSP. Higher postsurgical anxiety, acute pain intensity, and
frequency increased the likelihood of a worst PT. These results
are novel because there are no prospective studies onCPSP after
hysterectomy with such a long follow-up and that consider the
trajectory of pain over 2 long-term follow-up times (4 months and
5 years posthysterectomy). This study also adds to previous
findings regarding pain at 48 hours75,76 and 4 months79
postsurgery.
4.1. Chronic postsurgical pain prevalence
after hysterectomy
Almost half of women (48.2%) reported pain 4 months after
hysterectomy. Five years later, 17.1% still complained of pain.
Within hysterectomy studies, the longest follow-up period that we
are aware of (2 years) revealed a CPSP prevalence of 24.1% and
16% in abdominal and vaginal hysterectomy, respectively.67 With
a 1-year follow-up, Theunissen et al.100 reported a prevalence of
9%, although the criteria underlying CPSP definition was a cutoff
level of 3 (NRS . 3), indicative of moderate or severe pain
intensity. A retrospective study7 reported 31.9% prevalence and
in a prospective study,6 4 months postsurgery and using
a different CPSP definition (pain with impact on daily living), the
prevalence rate was 16.7%. Two other studies described
a prevalence of 14%103 and 26%,80 6 months posthysterectomy.
These figures clearly reveal large discrepancies in CPSP report,
most likely due to the diverse range of follow-up times and CPSP
definitions.48,69 The relatively higher prevalence of CPSP found in
our study may be due to not having included only those women
reporting moderate to severe pain (NRS. 3). On the other hand,
our findings show that pain only interfered with the lives of some
women and that interference was in the low-to-medium range.
4.2. Predictors of chronic postsurgical pain
after hysterectomy
4.2.1. Demographic and clinical factors
In contrast to earlier findings,6,7,67,79,97,100,103 age and presur-
gical pain did not predict CPSP. Studies that found such
relationships had shorter follow-ups, from 4 months to 2 years.
Consistent with previous results,3,6,7,97,100,103 hysterectomy type
did not predict CPSP albeit this does not support our earlier
findings,79 nor Montes et al.67 conclusions. These results were
unexpected and suggest that the strength of association of
demographic and clinical factors probably diminishes with time,
as psychological factors play an increasingly greater role. A similar
conclusion was drawn previously in a postmastectomy study with
a 3-year follow-up.2
Acute PSP intensity is a well-established key predictive
factor,13,14,52,55,61,62 including in hysterectomy CPSP stud-
ies.6,80,97,100,103 Present results support this and further add
PSP frequency, as previously found in this sample.76 To the best
of our knowledge, only Fletcher et al.35 found pain frequency to
be a CPSP predictor. These results highlight pain frequency as
a new potential target in CPSP prevention. When adding
postsurgical anxiety to the equation, both acute pain predictors
ceased to be significant, which indicates both their shared
variance and the unique contribution of postsurgical anxiety in the
prediction of CPSP.
Table 3
Incidence, characteristics, and impact of pain 5 years after
hysterectomy (N 5 29).
Pain 5 y after hysterectomy—T4 N (%) M (SD) Min-max
Pain report—CPSP* 29 (17.1)
Frequency
Daily 7 (24.2)
Several times a week but not daily 13 (44.8)
Several times a month but not weekly 3 (10.3)
During sexual intercourse/by touch 6 (20.7)
Intensity† (NRS 0-10)
Worst level 3.17 (1.61) 1-7
NRS . 3 10 (34.5)
Average level 1.89 (0.88) 1-4
NRS . 3 1 (3.4)
DN-4‡ (could report 1 or more)
Pins and needles 15 (51.7)
Numbness 9 (31.0)
Itching 6 (20.7)
Tingling 3 (10.3)
Burning 2 (6.9)
Painful cold 1 (3.4)
Electric shocks 1 (3.4)
DN4 , 3 23 (82.8)
DN4 $ 3 5 (17.2)
Pain interference§ (NRS 0-10)
General activity 12 (42.9) 1.07 (1.41) 0-4
Mood 16 (57.1) 1.64 (1.83) 0-5
Walking ability 8 (28.6) 0.57 (1.03) 0-3
Normal work 12 (42.9) 1.14 (1.56) 0-5
Relations with other people 5 (17.8) 0.32 (0.77) 0-3
Sleep 2 (7.2) 1.79 (0.67) 0-3
Enjoyment of life 14 (50) 1.32 (1.68) 0-5
Continuous variables are presented as mean (SD); categorical variables are presented as n (%).
* Women reporting CPSP—chronic postsurgical pain 5 years after hysterectomy.
† NRS: numerical rating scale (0-10).
‡ DN-4: Neuropathic Pain Questionnaire.
§ Items from BPI-SF: Brief Pain Inventory—short form.
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It is noteworthy that the acute postsurgical variables only
predicted pain 5 years later. This suggests that to prevent long-
term posthysterectomy pain, women should be screened and
targeted throughout the perioperative period, and not only before
surgery. Baseline assessments are useful for medium- and long-
term pain prediction, whereas acute postsurgical variables seem
to better predict long-term chronic pain.
4.2.2. The key role of psychological predictors
Presurgical anxiety and pain catastrophizing were predictive of an
unfavorable PSP trajectory and CPSP, which corroborates
previous findings.16,44,99 Presurgical anxiety, already shown to
be a predictor of CPSP 4 and 6 months79,103 posthysterectomy,
is also predictive of CPSP 5 years later. Furthermore, pain
catastrophizing, a well-established CPSP psychological risk
factor,2,15,50,56,83 emerges as a predictor for the first time in our
hysterectomy studies.79
Our results also confirm the important role of emotional
representation of the surgical disease and of postsurgical anxiety.79
Other studies have demonstrated the impact of cognitive and
affective responses triggered by illness on health outcomes,57,91
although the investigation of their predictive role on PSP has been
scarce.77,79 Postsurgical anxiety is such a response, present
findings highlighting the need to address anxiety throughout the
perioperative period, and not only before surgery.
Table 4
Multinomial logistic regressionmodel relating pain trajectory membership with presurgical variables measured 24 hours before
hysterectomy.
Pain trajectory comparison Presurgical models Nagelkerke R2 B SE Wald OR 95% CI
LL UL
Model 1A—emotional distress 0.206
PT1 vs PT2 Age† 20.036 0.024 2.334 0.964 0.920 1.010
Presurgical pain‡ 0.231 0.416 0.309 1.260 0.557 2.851
Type of hysterectomy§ 0.750 0.447 2.820 2.118 0.882 5.084
Presurgical anxiety‖ 0.123 0.051 5.924* 1.131 1.024 1.249
Presurgical fear{ 20.044 0.034 1.677 0.957 0.895 1.023
PT1 vs PT3 Age† 20.013 0.032 0.157 0.987 0.927 1.052
Presurgical pain‡ 0.706 0.534 1.752 2.026 0.712 5.767
Type of hysterectomy§ 1.010 0.621 2.650 2.747 0.814 9.273
Presurgical anxiety‖ 0.161 0.062 6.799** 1.175 1.041 1.326
Presurgical fear{ 0.031 0.035 0.802 1.032 0.964 1.104
PT2 vs PT3 Age† 0.024 0.034 0.471 1.024 0.957 1.095
Presurgical pain‡ 0.475 0.557 0.726 1.608 0.540 4.790
Type of hysterectomy§ 0.260 0.669 0.151 1.297 0.350 4.809
Presurgical anxiety‖ 0.038 0.062 0.376 1.039 0.920 1.173
Presurgical fear{ 0.075 0.038 3.880* 1.078 1.000 1.162
Model 1B‡‡—illness perceptions 0.171
PT1 vs PT2 Age† 20.030 0.023 1.697 0.970 0.928 1.015
Presurgical pain‡ 0.263 0.405 0.423 1.301 0.588 2.878
Type of hysterectomy§ 0.793 0.445 3.168 2.209 0.923 5.290
Emotional representation# 0.152 0.064 5.586* 1.165 1.026 1.321
PT1 vs PT3 Age† 20.018 0.030 0.378 0.982 0.926 1.041
Presurgical pain‡ 0.430 0.515 0.698 1.538 0.560 4.219
Type of hysterectomy§ 1.166 0.621 3.530 3.209 0.951 10.829
Emotional representation# 0.220 0.079 7.821** 1.246 1.068 1.455
Model 1C‡‡—pain coping strategies 0.178
PT1 vs PT2 Age† 20.037 0.023 2.611 0.963 0.921 1.008
Presurgical pain‡ 0.373 0.402 0.862 1.452 0.661 3.190
Type of hysterectomy§ 0.609 0.045 1.878 1.839 0.769 4.395
Pain catastrophizing†† 0.076 0.038 4.086* 1.079 1.002 1.162
PT1 vs PT3 Age† 20.034 0.031 1.172 0.967 0.910 1.028
Presurgical pain‡ 0.577 0.520 1.231 1.781 0.642 4.940
Type of hysterectomy§ 0.798 0.623 1.641 2.221 0.655 7.532
Pain catastrophizing†† 0.134 0.042 10.170*** 1.143 1.053 1.241
*P , 0.05; **P , 0.01; and ***P , 0.001.
PT1—Reference Group (In MODEL 1A PT2 vs PT3, PT2 is the reference group).
† Continuous variable, in years.
‡ Dichotomous variable: 0 5 no and 1 5 yes.
§ Dichotomous variable: 0 5 abdominal laparoscopic, vaginal, and vaginal-assisted laparoscopic and 1 5 open abdominal hysterectomies.
‖ Continuous variable, HADS-A: Hospital Anxiety and Depression Scale—anxiety subscale.
{ Continuous variable, Surgical Fear Questionnaire—fear of immediate consequences of surgery subscale.
# Continuous variable, IPQ-R: Illness Perception Questionnaire-Revised—all subscales.
†† Continuous variable, CSQ-R: Coping Strategies Questionnaire-Revised—all subscales.
‡‡ For models 1B and 1C, no significant predictors were found in the comparison of PT2 and PT3.
CI, confidence interval; LL, lower limit; OR, odds ratio; PT1, pain trajectory group 1 (no chronic postsurgical pain); PT2, pain trajectory group 2 (prolonged postsurgical pain); PT3, pain trajectory group 3 (chronic postsurgical
pain); UL, upper limit.
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Although all baseline psychological factors are common
predictive factors for both PT2 and PT3 membership, presurgical
fear of long-term consequences of surgery was the only variable
specifically distinguishing these groups. Hence, presenting
higher levels of fear related with long-term issues, such as fear
of health deterioration or long-lasting surgical recovery, seems to
confer a greater risk of long-lasting pain.
The set of predictive models used in this study, which include
preoperative and perioperative emotion and cognitions, seem to
reveal a psychological vulnerability profile, influencing PSP
trajectory and ultimately the development of CPSP. This critical
role of psychological factors on pain experience helps to
understand the discrepancy that sometimes emerges between
physical pathology, injury, and pain report.16,55,86,107 These
findings are also in accordance with the gate control and
neuromatrix theories of pain,64,65 as well as with the biopsy-
chosocial approach to pain,37 which recognize pain as a multi-
dimensional subjective experience.
Peripheral sensitization, central sensitization, and descending
modulation constitute 3 interweaved processes believed to
underlie CPSP.62 Augmented activation of pain pathways may
stem from peripheral and/or central sensitization, although pain
amplification may also arise from abnormalities in descending
modulatory systems.72,81,109 These descending pathways
involve endogenous opioids, serotonin, and noradrenaline,
presenting both excitatory and inhibitory actions on spinal cord
afferent projection neurons and could be activated by psycho-
logical factors.11 Catastrophizing, anxiety, and other negative
emotions are associated with reduced effectiveness in descend-
ing pain-inhibitory systems,83,105 facilitating spinal nociception,
and pain, whereas positive affect and self-regulatory skills inhibit
spinal nociception and pain.28,39,88–90 The primary role of
catastrophizing in pain modulation has been high-
lighted16,18,34,39,50,94 and suggested to be associated with
diminished endogenous inhibition of pain coupled with central
sensitization.83 Moreover, an association was shown between
adaptive pain coping strategies and activation of descending
endogenous opioid systems1 and between depressedmood and
impaired endogenous inhibition of pain.30
4.3. Practical and clinical implications
Because chronic pain is very difficult to treat, the importance of
secondary prevention is highlighted.38,93 Besides, and despite
the enthusiastic and promising findings of some trials focusing on
preventive analgesic approaches,10,12,21,29,74,96 there is not yet
any robust evidence to support the unequivocal efficacy of
systemic drugs for CPSP prevention.9,17,19,43,53,60,63,86
Table 5
Multinomial logistic regression model relating pain trajectory membership with postsurgical variables measured 48 hours after
hysterectomy.
Pain trajectory comparison Postsurgical models Nagelkerke R2 B SE Wald OR 95% CI
LL UL
Model 2A††—acute pain 0.192
PT1 vs PT2 Age 20.031 0.023 1.774 0.970 0.927 1.015
Presurgical pain‡ 0.289 0.404 0.511 1.335 0.605 2.946
Type of hysterectomy§ 0.640 0.443 2.083 1.896 0.795 4.552
Acute postsurgical pain intensity‖ 0.067 0.069 0.957 1.070 0.935 1.224
Acute postsurgical pain frequency{ 0.429 0.431 0.992 1.535 0.660 3.571
PT1 vs PT3 Age 20.011 0.032 0.114 0.989 0.929 1.053
Presurgical pain‡ 0.388 0.527 0.543 1.474 0.525 4.139
Type of Hysterectomy§ 0.765 0.634 1.457 2.149 0.620 7.441
Acute postsurgical pain intensity‖ 0.191 0.090 4.525* 1.211 1.015 1.444
Acute postsurgical pain frequency{ 1.099 0.505 4.741* 3.000 1.116 8.065
Model 2B††—Acute pain 1 anxiety 0.222
PT1 vs PT2 Age† 20.031 0.023 1.743 0.970 0.926 1.015
Presurgical pain‡ 0.360 0.410 0.771 1.433 0.642 3.201
Type of hysterectomy§ 0.637 0.446 2.041 1.890 0.789 4.527
Acute postsurgical pain intensity‖ 0.031 0.074 0.172 1.031 0.892 1.192
Acute postsurgical pain frequency{ 0.306 0.445 0.474 1.358 0.568 3.250
Postsurgical anxiety# 0.093 0.068 1.863 1.098 0.960 1.255
PT1 vs PT3 Age† 20.016 0.033 0.234 0.984 0.923 1.050
Presurgical pain‡ 0.430 0.536 0.643 1.537 0.538 4.391
Type of hysterectomy§ 0.715 0.646 1.224 2.044 0.576 7.255
Acute postsurgical pain intensity‖ 0.123 0.097 1.620 1.131 0.936 1.367
Acute postsurgical pain frequency{ 0.786 0.536 2.152 2.195 0.768 6.277
Postsurgical anxiety# 0.167 0.075 4.945* 1.182 1.020 1.370
*P , 0.05; **P , 0.01; and ***P , 0.001.
PT1—Reference Group.
† Continuous variable, in years.
‡ Dichotomous variable: 0 5 no and 1 5 yes.
§ Dichotomous variable: 0 5 abdominal laparoscopic, vaginal, and vaginal-assisted laparoscopic and 1 5 open abdominal hysterectomies.
‖ Continuous variable, NRS 0 to 10 from BPI-SF: Brief Pain Inventory—short form.
{ Dichotomous variable: 0 5 intermittent or brief pain, 1 5 constant pain, frequency subscale of McGill Pain Questionnaire.
# Continuous variable, HADS-A: Hospital Anxiety and Depression Scale—anxiety subscale.
†† For models 2A and 2B, no significant predictors were found in the comparison of PT2 and PT3.
CI, confidence interval; LL, lower limit; NRS, numerical rating scale; OR, odds ratio; PT1, pain trajectory group 1 (no chronic postsurgical pain); PT2, pain trajectory group 2 (prolonged postsurgical pain); PT3, pain trajectory
group 3 (chronic postsurgical pain); UL, upper limit.
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Moreover, notwithstanding the advances in knowledge about
pain genetics,22,31,32,70,71 there is not, until now, sustained
evidence for genetic predisposition for CPSP develop-
ment22,48,67,86 that could assist in screening for pain-prone
patients and in informing a personalized pain treatment protocol.
This leaves room for the implementation of psychological
interventions aimed at preventing CPSP.15,23,33,47–49,62,99 In-
deed, present findings point to CPSP predictors that are
modifiable risk factors, amenable to change or to active
management, precisely through psychological interventions.
Targeting them might yield adaptive and functional changes in
brain pain processing, thus being an effective way to prevent
CPSP development.34,94
The effectiveness of psychological interventions in pain is well
established,36,46 although in the surgical field it is overdue.15,47,55
As substantial advances are being made in identifying risk factors
for CPSP, the design and testing of preventive pain management
strategies stemming from this evidence is warranted as well as
the analysis of their cost-effectiveness. An enthusiastic and
promising novelty in this field is the development and implemen-
tation of a Transitional Pain Service, a multidisciplinary program
aimed at preventing and managing CPSP, which offers simulta-
neous psychological and pharmacological
interventions.20,23,42,49
Psychological interventions have the power to impact supra-
spinal mechanisms involving higher pain centers,62 influencing
endogenous modulation of pain, thereby improving endogenous
analgesia, similarly to mechanisms underlying pharmacological
analgesia.34,45,46,83 For example, cognitive-behavioral therapy
has been related to changes in brain limbic activity, which has
been implicated in improvement of anxiety and potentiation of
descending modulatory inhibition of pain.54,106 Increased gray
matter in prefrontal and parietal brain regions linked with chronic
pain, was also observed after cognitive-behavioral therapy, being
associated with a decrease in pain catastrophizing.95
4.4. Limitations and strengths
This is a single-site and single-country study, which compromises
its external validity, thus limiting the generalization of results.
Sample attrition is a potential limitation, stemming from the
longitudinal design, although our study showed high retention
over time. Other potential limitation is the absence of a physical
examination at T3 and T4, screening for inflammation or nerve
injury.
The breath of presurgical measures, embracing demographic,
clinical, and a thorough range of psychological variables was
a strength, along with the long-term follow-up of 5 years.
4.5. Conclusions
This study identified risk factors that can be easily screened
before and after surgery, and are amenable to intervention. The
design of timely and tailored interventions for women at risk of an
unfavorable PSP trajectory after hysterectomy is a key priority.
Incorporating risk-targeted multidisciplinary and feasible inter-
ventions focused on CPSP prevention into surgical routine
practice is an important challenge that is likely to contribute to
the improvement of pain management and patient care
throughout the process of surgery.
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